This hIgA is purified from human plasma and is suitable for immunization or controls.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
100 mM Tris-HCl, pH 8.0, with 100 M NaCl and 0.05 % NaN3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Aliquot and store at -20 °C.
Target
IgA
Substanzklasse
Antibody
Hintergrund
IgA antibodies play a central role in defence against pathogens by preventing adhesion penetration. Reduced levels can be due to a congenital deficiency, to certain disorders (IgG myeloma and lymphoma) or in response to certain drugs. Very high levels of monoclonal IgA are associated with IgA myeloma, benign blood globulin disorders in elderly patients and certain severe infectious diseases.